Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership10,647,313 shares
Ownership 4.20%
Jpmorgan Chase & Co ownership in VRTX / Vertex Pharmaceuticals Incorporated

2016-12-08 - Jpmorgan Chase & Co has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,647,313 shares of Vertex Pharmaceuticals Incorporated (US:VRTX). This represents 4.2 percent ownership of the company. In their previous filing dated 2016-02-01 , Jpmorgan Chase & Co had reported owning 12,630,441 shares, indicating a decrease of -15.70 percent.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 111,500 of underlying shares valued at $49,412,340 USD and put options representing 75,300 of underlying shares valued at $33,369,948 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2016-12-08 2016-12-08 13G/A 12,630,441 10,647,313 -15.70 4.20 -17.65
2016-02-01 2016-02-01 13G 12,630,441 5.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 7,033,156 993,675 16.45 3,116,814 13.83 0.2002
2026-02-11 2025-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,039,481 -395,297 -6.14 2,738,059 8.65 0.1719
2025-11-26 2025-09-30 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 6,434,778 565,417 9.63 2,520,139 -3.56 0.1510
2025-11-07 2025-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,434,778 565,417 2,520,139 0.1510
2025-08-12 2025-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 5,869,361 -1,886,284 -24.32 2,613,065 -30.51 0.1709
2025-05-12 2025-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 7,755,645 1,442,538 22.85 3,760,092 47.90 0.2746
2025-02-12 2024-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,313,107 -615,480 -8.88 2,542,289 -21.10 0.1893
2024-12-26 2024-09-30 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 6,928,587 328,802 4.98 3,222,348 4.17 0.2449
2024-11-08 2024-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,928,587 328,802 3,222,348 0.2456
2024-12-26 2024-06-30 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 6,599,785 581,661 9.67 3,093,452 22.97 0.2536
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,599,785 581,661 3,093,452 0.2541
2024-12-26 2024-03-31 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 6,018,124 393,859 7.00 2,515,636 9.93 0.2125
2024-05-10 2024-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,018,124 393,859 2,515,636 0.2128
2024-12-26 2023-12-31 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 5,624,265 -481,587 -7.89 2,288,457 7.78 0.2195
2024-02-12 2023-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 5,624,265 -481,587 2,288,457 0.2199
2023-11-14 2023-09-30 13F Vertex Pharmaceuticals COM 92532F100 6,105,852 150,327 2.52 2,123,249 1.31 0.2343
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 5,955,525 -405,233 -6.37 2,095,809 4.58 0.2277
2023-05-18 2023-03-31 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 6,360,758 870,350 15.85 2,004,085 126,340.63 0.2441
2023-05-11 2023-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,239,768 749,360 2,004,085 0.0297
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 5,490,408 630,721 12.98 1,586 -99.89 0.2090
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 4,859,687 -377,855 -7.21 1,407,074 -4.66 0.2021
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 5,237,542 424,873 8.83 1,475,887 17.51 0.2056
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 4,812,669 348,338 7.80 1,255,961 28.11 0.1513
2022-02-11 2021-12-31 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 4,464,331 252,599 6.00 980,368 28.33 0.1132
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 4,464,331 252,599 980,368 0.1122
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 4,211,732 -226,331 -5.10 763,967 -14.63 0.0945
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 4,438,063 1,231,763 38.42 894,846 29.88 0.1068
2021-05-12 2021-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,206,300 618,276 23.89 689,000 12.65 0.0920
2021-02-19 2020-12-31 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 2,588,024 348,214 15.55 611,653 1.03 0.0899
2021-02-11 2020-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 2,588,024 348,214 611,653 15,126.6146
2020-11-12 2020-09-30 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 2,239,810 126,724 6.00 605,443 -1.31 0.1017
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 2,239,810 605,443
2020-08-11 2020-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 2,113,086 -81,689 -3.72 613,449 17.46 0.1184
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 2,194,775 -390,614 -15.11 522,247 -7.74 0.1226
2020-02-11 2019-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 2,585,389 -788,425 -23.37 566,071 -0.97 0.1056
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,373,814 -959,889 -22.15 571,590 -26.14 0.1138
2019-08-07 2019-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 4,333,703 -2,449,932 -36.12 773,913 -37.98 0.1513
2019-05-07 2019-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,783,635 -403,886 -5.62 1,247,848 4.77 0.2549
2019-02-11 2018-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 7,187,521 70,305 0.99 1,191,043 -13.17 0.2754
2018-11-13 2018-09-30 13F/A-1 VERTEX PHARMACEUTICALS COMMON 92532F100 7,117,216 355,139 5.25 1,371,769 19.36 0.2627
2018-11-07 2018-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 7,117,216 355,139 1,371,769
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,762,077 -1,222,383 -15.31 1,149,282 -11.68 0.2363
2018-05-10 2018-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 7,984,460 -1,413,492 -15.04 1,301,310 -7.60 0.2789
2018-02-13 2017-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 9,397,952 75,505 0.81 1,408,376 0.97 0.2967
2017-11-09 2017-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 9,322,447 939,894 11.21 1,394,827 29.12 0.3077
2017-08-09 2017-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 8,382,553 -978,823 -10.46 1,080,260 5.53 0.2469
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 9,361,376 -1,235,572 -11.66 1,023,665 31.08 0.2339
2017-02-06 2016-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 10,596,948 -430,141 -3.90 780,923 -18.83 0.1876
2016-11-04 2016-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 11,027,089 -1,146,350 -9.42 962,112 -8.12 0.2368
2016-08-08 2016-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 12,173,439 485,112 4.15 1,047,161 12.71 0.2611
2016-05-10 2016-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 11,688,327 -929,737 -7.37 929,105 -41.48 0.2378
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 12,618,064 1,133,873 9.87 1,587,733 32.76 0.3986
2015-11-13 2015-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 11,484,191 905,507 8.56 1,195,964 -8.44 0.3197
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 10,578,684 394,066 3.87 1,306,254 8.72 0.3079
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 10,184,618 -241,616 -2.32 1,201,479 -3.00 0.2736
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 10,426,234 -165,171 -1.56 1,238,635 4.13 0.2832
2014-12-08 2014-09-30 13F/A-1 VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 10,591,405 955,407 9.91 1,189,520 30.38 0.2819
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 10,591,405 1,189,520
2014-09-03 2014-06-30 13F/A-1 VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 9,635,998 2,029,309 26.68 912,335 69.60 0.2317
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 9,635,998 912,335
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 7,606,689 -1,573,569 -17.14 537,946 -21.13 0.1484
2014-02-26 2013-12-31 13F/A-1 VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 9,180,258 1,554,124 20.38 682,094 17.97 0.1935
2014-02-13 2013-12-31 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 9,180,258 682,094
2013-10-31 2013-09-30 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 7,626,134 748,645 10.89 578,215 5.01 0.1713
2013-08-13 2013-06-30 13F VERTEX PHARMACEUTICALS INCORPO COMMON 92532F100 6,877,489 6,877,489 550,613 0.1755
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A VERTEX PHARMACEUTICALS OPTION Call 111,500 24.86 49,412 22.05 n/a n/a n/a
2026-02-11 2025-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 89,300 -32.25 40,485 -21.57 n/a n/a n/a
2025-11-26 2025-09-30 13F/A VERTEX PHARMACEUTICALS OPTION Call 131,800 1,657.33 51,618 1,445.91 n/a n/a n/a
2025-11-07 2025-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 131,800 51,618 n/a n/a n/a
2025-08-12 2025-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 7,500 -76.19 3,339 -78.14 n/a n/a n/a
2025-05-12 2025-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 31,500 -31.97 15,272 -18.10 n/a n/a n/a
2025-02-12 2024-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 46,300 -61.83 18,645 -66.95 n/a n/a n/a
2024-12-26 2024-09-30 13F/A VERTEX PHARMACEUTICALS OPTION Call 121,300 282.65 56,414 279.69 n/a n/a n/a
2024-11-08 2024-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 121,300 56,414 n/a n/a n/a
2024-12-26 2024-06-30 13F/A VERTEX PHARMACEUTICALS OPTION Call 31,700 -24.52 14,858 -15.37 n/a n/a n/a
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 31,700 14,858 n/a n/a n/a
2024-12-26 2024-03-31 13F/A VERTEX PHARMACEUTICALS OPTION Call 42,000 -8.70 17,556 -6.20 n/a n/a n/a
2024-05-10 2024-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 42,000 17,556 n/a n/a n/a
2024-12-26 2023-12-31 13F/A VERTEX PHARMACEUTICALS OPTION Call 46,000 13.58 18,717 32.90 n/a n/a n/a
2024-02-12 2023-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 46,000 18,717 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 40,500 123.76 14,083 121.12 n/a n/a n/a
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 18,100 162.32 6,370 192.96 n/a n/a n/a
2023-05-18 2023-03-31 13F/A VERTEX PHARMACEUTICALS OPTION Call 6,900 -87.48 2,174 14,393.33 n/a n/a n/a
2023-05-11 2023-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 6,900 2,174 n/a n/a n/a
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 55,100 7.20 16 -99.90 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 51,400 0.00 14,882 2.75 n/a n/a n/a
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 51,400 242.67 14,484 269.96 n/a n/a n/a
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 15,000 2,900.00 3,915 3,459.09 n/a n/a n/a
2022-02-11 2021-12-31 13F/A VERTEX PHARMACEUTICALS OPTION Call 500 0.00 110 20.88 n/a n/a n/a
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 500 110 n/a n/a n/a
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 500 0.00 91 -9.90 n/a n/a n/a
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 500 -99.85 101 -99.86 n/a n/a n/a
2021-05-12 2021-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 325,100 69,861 n/a n/a n/a
2020-11-12 2020-09-30 13F/A VERTEX PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-11 2020-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 40,000 -52.83 11,612 -42.45 n/a n/a n/a
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 84,800 158.54 20,178 180.95 n/a n/a n/a
2020-02-11 2019-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 32,800 51.85 7,182 96.28 n/a n/a n/a
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 21,600 68.75 3,659 60.06 n/a n/a n/a
2019-08-07 2019-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 12,800 -90.83 2,286 -91.10 n/a n/a n/a
2019-05-07 2019-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 139,600 567.94 25,679 641.52 n/a n/a n/a
2019-02-11 2018-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 20,900 -18.04 3,463 -29.54 n/a n/a n/a
2018-11-13 2018-09-30 13F/A VERTEX PHARMACEUTICALS OPTION Call 25,500 -61.71 4,915 -56.58 n/a n/a n/a
2018-11-07 2018-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 25,500 4,915 n/a n/a n/a
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 66,600 24.72 11,319 30.06 n/a n/a n/a
2018-05-10 2018-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 53,400 673.91 8,703 741.68 n/a n/a n/a
2018-02-13 2017-12-31 13F VERTEX PHARMACEUTICALS OPTION Call 6,900 6.15 1,034 6.27 n/a n/a n/a
2017-11-09 2017-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 6,500 973 n/a n/a n/a
2017-08-09 2017-06-30 13F VERTEX PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS OPTION Call 67,500 170.00 7,381 238.58 n/a n/a n/a
2016-11-04 2016-09-30 13F VERTEX PHARMACEUTICALS OPTION Call 25,000 2,180 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A VERTEX PHARMACEUTICALS OPTION Put 75,300 502.40 33,370 488.83 n/a n/a n/a
2026-02-11 2025-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 12,500 -54.55 5,667 -47.38 n/a n/a n/a
2025-11-26 2025-09-30 13F/A VERTEX PHARMACEUTICALS OPTION Put 27,500 -12.42 10,770 -22.96 n/a n/a n/a
2025-11-07 2025-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 27,500 10,770 n/a n/a n/a
2025-08-12 2025-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 31,400 -0.32 13,979 -8.46 n/a n/a n/a
2025-05-12 2025-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 31,500 50.00 15,272 80.59 n/a n/a n/a
2025-02-12 2024-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 21,000 0.00 8,457 -13.41 n/a n/a n/a
2024-12-26 2024-09-30 13F/A VERTEX PHARMACEUTICALS OPTION Put 21,000 0.00 9,767 -0.78 n/a n/a n/a
2024-11-08 2024-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 21,000 9,767 n/a n/a n/a
2024-12-26 2024-06-30 13F/A VERTEX PHARMACEUTICALS OPTION Put 21,000 -59.69 9,843 -54.80 n/a n/a n/a
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 21,000 9,843 n/a n/a n/a
2024-12-26 2024-03-31 13F/A VERTEX PHARMACEUTICALS OPTION Put 52,100 -36.62 21,778 -34.89 n/a n/a n/a
2024-05-10 2024-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 52,100 21,778 n/a n/a n/a
2024-12-26 2023-12-31 13F/A VERTEX PHARMACEUTICALS OPTION Put 82,200 66.73 33,446 95.10 n/a n/a n/a
2024-02-12 2023-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 82,200 33,446 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 49,300 122.07 17,144 119.44 n/a n/a n/a
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 22,200 -4.31 7,812 6.87 n/a n/a n/a
2023-05-18 2023-03-31 13F/A VERTEX PHARMACEUTICALS OPTION Put 23,200 56.76 7,310 182,650.00 n/a n/a n/a
2023-05-11 2023-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 23,200 7,310 n/a n/a n/a
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 14,800 105.56 4 -99.81 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 7,200 12.50 2,085 15.64 n/a n/a n/a
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 6,400 3,100.00 1,803 3,367.31 n/a n/a n/a
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 200 -99.49 52 -99.39 n/a n/a n/a
2022-02-11 2021-12-31 13F/A VERTEX PHARMACEUTICALS OPTION Put 39,100 0.00 8,586 21.07 n/a n/a n/a
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 39,100 8,586 n/a n/a n/a
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 39,100 0.00 7,092 -10.05 n/a n/a n/a
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 39,100 -82.54 7,884 -83.61 n/a n/a n/a
2021-05-12 2021-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 223,900 48,114 n/a n/a n/a
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-11 2019-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 46,300 76.05 10,137 127.49 n/a n/a n/a
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 26,300 0.00 4,456 -5.13 n/a n/a n/a
2019-08-07 2019-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 26,300 -57.65 4,697 -58.88 n/a n/a n/a
2019-05-07 2019-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 62,100 58.82 11,423 76.31 n/a n/a n/a
2019-02-11 2018-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 39,100 1.56 6,479 -12.68 n/a n/a n/a
2018-11-13 2018-09-30 13F/A VERTEX PHARMACEUTICALS OPTION Put 38,500 -30.88 7,420 -21.62 n/a n/a n/a
2018-11-07 2018-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 38,500 7,420 n/a n/a n/a
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 55,700 -16.11 9,467 -12.52 n/a n/a n/a
2018-05-10 2018-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 66,400 233.67 10,822 262.91 n/a n/a n/a
2018-02-13 2017-12-31 13F VERTEX PHARMACEUTICALS OPTION Put 19,900 -90.46 2,982 -90.44 n/a n/a n/a
2017-11-09 2017-09-30 13F VERTEX PHARMACEUTICALS OPTION Put 208,500 31,196 n/a n/a n/a
2017-08-09 2017-06-30 13F VERTEX PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS OPTION Put 45,400 4,964 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.